PDCD4 and neoplasm: Loss or downregulation of PDCD4 is associated with tumor progression and poor outcomes in different malignancies, such as head and neck, brain, breast, lung, digestive, reproductive, and urinary system cancers [23,24,25,26,27,28,37].